Sandeep Gurbuxani to Lymphoma, B-Cell
This is a "connection" page, showing publications Sandeep Gurbuxani has written about Lymphoma, B-Cell.
Connection Strength
0.439
-
Outcomes After Retreatment With Inotuzumab Ozogamicin for Relapsed/Refractory Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic Leukemia. JCO Precis Oncol. 2022 10; 6:e2200353.
Score: 0.176
-
B-cell lymphoma-2 downregulation is a useful feature supporting a neoplastic phenotype in mature T-cell lymphomas. Hum Pathol. 2022 07; 125:48-58.
Score: 0.171
-
Stem cell factor expression in B cell malignancies is influenced by the niche. Leuk Lymphoma. 2013 Oct; 54(10):2274-80.
Score: 0.091